Seeds Investor’s Novartis NVS Stock Holding History

Seeds Investor’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$968K	Sell	6,174 -329	-5%	-$49.3K	0.1%	150
2026 Q1	$997K	Buy	6,503 +533	+9%	+$81.7K	0.14%	125
2025 Q4	$823K	Buy	5,970 +423	+8%	+$55.4K	0.16%	97
2025 Q3	$711K	Buy	5,547 +120	+2%	+$14.6K	0.15%	93
2025 Q2	$657K	Buy	5,427 +428	+9%	+$48.2K	0.15%	91
2025 Q1	$557K	Sell	4,999 -221	-4%	-$23.5K	0.16%	95
2024 Q4	$508K	Buy	5,220 +261	+5%	+$27.8K	0.14%	107
2024 Q3	$570K	Buy	4,959 +728	+17%	+$82.6K	0.21%	86
2024 Q2	$450K	Buy	4,231 +823	+24%	+$82.6K	0.23%	90
2024 Q1	$330K	Buy	+3,408	New	+$349K	0.3%	90

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Seeds Investor's NVS Position: Q2 2026 in Review

Seeds Investor reduced its Novartis (NVS) stake by 5.1% in Q2 2026, selling an estimated $49.3K and leaving 6,174 shares worth $968K. The position accounts for 0.1% of the portfolio, ranked #150.

Seeds Investor first reported a position in NVS in Q1 2024 and has held it in 10 quarters since. The position peaked at $997K in Q1 2026. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Seeds Investor held 6,174 shares of Novartis worth $968K as of Q2 2026.
Seeds Investor sold 329 Novartis shares in Q2 2026, an estimated $49.3K.
Novartis made up 0.1% of Seeds Investor's portfolio in Q2 2026, its #150 holding.
Seeds Investor first reported a position in Novartis in Q1 2024 and has held it in 10 quarters since.
Seeds Investor's Novartis position peaked at $997K in Q1 2026.
1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Seeds Investor's 13F filing for Q2 2026, filed 12 Aug 2026.